Novo Nordisk to restart Phase III haemophilia trials of concizumab
Novo Nordisk is set to resume the Phase III explorer 6, 7 and 8 clinical...
Orphazyme finds reduced Niemann-Pick disease progression in trial
Biopharmaceutical firm Orphazyme has reported positive interim results from an open-label extension study of a...
Bavarian Nordic reports Phase III data for smallpox vaccine
Bavarian Nordic has reported data from the Phase III efficacy study of MVA-BN (Jynneos) vaccine,...
Bavarian Nordic reports Phase II bladder cancer trial data
Bavarian Nordic has reported results from the first stage of a Phase II clinical trial...
Bavarian Nordic begins equine encephalitis virus vaccine trial
Bavarian Nordic has started a Phase I clinical trial to assess its vaccine candidate MVA-BN...
Zealand reports results of paediatric Phase 3 trial for hypoglycaemia
Denmark-based biotechnology company Zealand Pharma has reported positive outcome for its dasiglucagon in the paediatric...
Novo Nordisk reports positive data for oral semaglutide
Novo Nordisk has reported positive results from the Phase IIIa PIONEER clinical trial programme of...
MC2 Therapeutics enrols patents for trial of MC2-01 PAD Cream
MC2 Therapeutics has completed enrollment for its Phase III study of MC2-01 PAD Cream to...
Gilead and Novo partner to trial combination therapy for NASH
Gilead Sciences has entered a clinical collaboration with Denmark-based Novo Nordisk to evaluate a combination...
Janssen to study daratumumab in Phase III trial
Danish biotechnology firm Genmab has announced that Janssen Biotech will conduct a Phase III clinical...